There are 140 resources available
54P - Real-world data of patients with recurrent BRCA-mutated platinum-sensitive ovarian cancer treated with olaparib maintenance: Surgical outcome subgroup analysis from the C-PATROL study
Presenter: Frederik Marmé
Session: Poster Display
55P - Long-term responders (LTR) with niraparib maintenance in platinum-sensitive recurrent high-grade serous ovarian cancer (PSROC) focusing on subsequent therapies and post-progression outcomes (GEICO-88R study)
Presenter: Juan Cueva Banuelos
Session: Poster Display
56P - Real-life data for HRD testing from the only French platform using the Myriad MyChoice test
Presenter: Romain Boidot
Session: Poster Display
57P - Prognostic impact of functional domain of BRCA1/2 mutation in platinum-sensitive recurrent epithelial ovarian cancer patients receiving PARP inhibitors
Presenter: Francesca Stella Mosimann
Session: Poster Display
58P - A multicenter, prospective, non-interventional drug intensive monitoring study of olaparib in real-world Chinese patients with ovarian cancer (DIM-OC)
Presenter: Zhong Qiu Lin
Session: Poster Display
59P - Real-world effectiveness of niraparib in recurrent ovarian cancer patients in France: Impact of starting dose and timing of the maintenance initiation
Presenter: Brunhilde Hanvic
Session: Poster Display
60P - Exploration of homologous recombination deficiency testing in ovarian cancer: Insight from an Italian referral center
Presenter: Floriana Camarda
Session: Poster Display
61P - Prognostic impact in ovarian cancer carriers of mutations located in cluster with higher risk of ovarian cancer in BRCA
Presenter: Pablo Torres-Mozas
Session: Poster Display
62P - A multi-center real-world study of the efficacy and safety of PARP inhibitors in patients with ovarian cancer in Spain
Presenter: Rodrigo Sanchez Bayona
Session: Poster Display
63P - A real-world comparison of the tolerability and toxicity of niraparib in older and younger women with high-grade serous ovarian carcinoma
Presenter: Samantha Low
Session: Poster Display